Roman Zelchan

483 total citations
55 papers, 264 citations indexed

About

Roman Zelchan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roman Zelchan has authored 55 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roman Zelchan's work include Radiopharmaceutical Chemistry and Applications (35 papers), Medical Imaging Techniques and Applications (18 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Roman Zelchan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (35 papers), Medical Imaging Techniques and Applications (18 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Roman Zelchan collaborates with scholars based in Russia, Sweden and United States. Roman Zelchan's co-authors include Olga Bragina, Anna Orlova, В. И. Чернов, Vladimir Tolmachev, В. И. Чернов, Jens Sørensen, Anzhelika Vorobyeva, Л. А. Таширева, Mei Li and Alexey Schulga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Roman Zelchan

44 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Zelchan Russia 8 197 111 56 40 25 55 264
Jennie Malmberg Sweden 11 398 2.0× 224 2.0× 74 1.3× 136 3.4× 24 1.0× 12 460
Anika Brunegraf Germany 5 287 1.5× 73 0.7× 230 4.1× 59 1.5× 16 0.6× 7 388
Yung-Hua Wang United States 9 102 0.5× 116 1.0× 60 1.1× 90 2.3× 45 1.8× 18 282
Natsuki Honda Japan 6 276 1.4× 132 1.2× 76 1.4× 46 1.1× 31 1.2× 12 366
Koen Vermeulen Belgium 7 142 0.7× 70 0.6× 73 1.3× 85 2.1× 8 0.3× 19 254
Chang‐Sok Oh United States 9 215 1.1× 81 0.7× 102 1.8× 67 1.7× 64 2.6× 9 310
L.M. Keller United States 10 92 0.5× 103 0.9× 77 1.4× 100 2.5× 44 1.8× 15 342
Yana Dekempeneer Belgium 7 300 1.5× 142 1.3× 87 1.6× 64 1.6× 6 0.2× 12 348
Lawrence Dierickx France 10 127 0.6× 93 0.8× 50 0.9× 38 0.9× 28 1.1× 33 275
Irina Heid Germany 10 96 0.5× 155 1.4× 24 0.4× 105 2.6× 49 2.0× 19 334

Countries citing papers authored by Roman Zelchan

Since Specialization
Citations

This map shows the geographic impact of Roman Zelchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Zelchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Zelchan more than expected).

Fields of papers citing papers by Roman Zelchan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Zelchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Zelchan. The network helps show where Roman Zelchan may publish in the future.

Co-authorship network of co-authors of Roman Zelchan

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Zelchan. A scholar is included among the top collaborators of Roman Zelchan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Zelchan. Roman Zelchan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tretyakova, M. V., Evgenii Plotnikov, Roman Zelchan, et al.. (2025). Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors. International Journal of Molecular Sciences. 26(21). 10609–10609. 1 indexed citations
3.
Zelchan, Roman, В. И. Чернов, Alexey Schulga, et al.. (2024). Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer. Cancers. 16(16). 2815–2815. 5 indexed citations
4.
6.
Abouzayed, Ayman, Sophia Hober, Roman Zelchan, et al.. (2023). The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity. Diagnostics. 13(9). 1611–1611. 3 indexed citations
7.
Bragina, Olga, В. И. Чернов, Roman Zelchan, et al.. (2023). Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer. Theranostics. 13(14). 4858–4871. 21 indexed citations
8.
Plotnikov, Evgenii, Roman Zelchan, Alexey Schulga, et al.. (2022). Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer. International Journal of Molecular Sciences. 23(21). 13443–13443. 4 indexed citations
9.
Чернов, В. И., et al.. (2021). The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas. SHILAP Revista de lepidopterología. 20(2). 120–129.
12.
Bragina, Olga, Javad Garousi, Roman Zelchan, et al.. (2020). Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer. Journal of Nuclear Medicine. 62(4). 493–499. 40 indexed citations
13.
Zelchan, Roman, et al.. (2019). POSSIBILITIES OF 18F-FDG PET/CT IN THE DIAGNOSIS AND STAGING OF LYMPHOMAS. Voprosy Onkologii. 65(1). 147–153. 2 indexed citations
14.
Bragina, Olga, et al.. (2019). SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH 99MTC-1-THIO-D-GLUCOSE FOR METABOLIC BREAST CANCER IMAGING. Russian Electronic Journal of Radiology. 9(4). 82–96. 2 indexed citations
15.
Чернов, В. И., et al.. (2018). THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS. Siberian Journal of Oncology. 17(4). 81–87. 5 indexed citations
17.
Zelchan, Roman, et al.. (2016). POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY. Siberian Journal of Oncology. 1 indexed citations
18.
Чернов, В. И., et al.. (2016). RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES. Siberian Journal of Oncology. 15(2). 101–106. 7 indexed citations
19.
Чернов, В. И., et al.. (2015). Radionuclide Methods in the Assessment of Anthracycline-Induced Cardiotoxicity. Kardiologiia. 7_2015(7). 57–62. 3 indexed citations
20.
Чернов, В. И., et al.. (2012). Using of 199Tl-сhloride and 99mTc-MIBI in indications and differential diagnostics inflammatory and neoplastic processes of musculoskeletal system. SHILAP Revista de lepidopterología. 11(3). 120–131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026